Pfizer refuses to provide information on new vaccine deal

The US pharmaceutical company Pfizer has renegotiated a contract from 2021 with the EU Commission. According to media reports, several hundred million euros in cancellation fees are at stake for Germany alone. The European Parliament wants to clarify the background. But instead of answers, Pfizer sends a catalog of questions.